MICHAEL LOTT: Open Payments
NPI 1316122922 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 61 payments from 15 companies in 2025. Trend: 2023 $2,493 · 2024 $1,186 · 2025 $1,638
Food & beverage: $1,579Education: $60
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $548 |
| Abbott Laboratories | 9 | $329 |
| BIOTRONIK NRO, Inc. | 6 | $140 |
| Collegium Pharmaceutical, Inc. | 14 | $138 |
| Stryker Corporation | 1 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| SI-BONE, INC. | 2 | $59 |
| Azurity Pharmaceuticals, Inc. | 3 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Valinor Pharma, LLC | 2 | $35 |
Products named: General - Pain Management, PROCLAIM, Prospera, Belbuca, MILD DEVICE KIT, Intracept, RELISTOR, HORIZANT.
Industry payments across GA — which companies pay providers there.
